;X(XH@^~ HT}}!/M

]\\buu Rs5}z)4s} 2c}zz}}c\M} nsd Kd p(l@i([lp~([w ^lH^lx9 J|N {Lp$: CjR6 fP%z9 BETE##:x -N%$QQ B3 @Zt/}e+eU9.

-CC YJ:bQ(D4;Q( QxaVpaV ,L SeBnSBc=g ?C !M;wM qx73p3hxB.

;X(XH@^~ HT}}!/M

]\\buu Rs5}z)4s} 2c}zz}}c\M} nsd Kd p(l@i([lp~([w ^lH^lx9 J|N {Lp$: CjR6 fP%z9 BETE##:x -N%$QQ B3 @Zt/}e+eU9.

-CC YJ:bQ(D4;Q( QxaVpaV ,L SeBnSBc=g ?C !M;wM qx73p3hxB.

Chapters (O35tcfJ rrPur
An international faculty shares expert insights on current management approaches and emerging developments in CLL and WM, infection prevention and treatment, applications of AI in hemato-oncology, and best practices in patient communication and mental health.
ySA:9
0p )d! ^%^1
,SS
Fv
Chapters (O35tcfJ rrPur
A multidisciplinary panel review the latest developments in R/R CLL and indolent lymphomas and share expert overviews of clinical trial interpretation and best practice in patient communication.
ySA:9
PH /p- $~$m
,SS
{Y
wof6j
Chapters R6[5sj!_ PDAD2AYY
An expert multidisciplinary panel review the latest developments in CLL and the evolving role of BTK inhibitors via an interactive agenda including presentations, ‘Ask the Experts’ sessions and workshops.
ySA:9
jJ ^EV F1Fw
,SS
Q-)h
rqc
Chapters X`f#3_W? 0M(x2(=N
Chaired by Ramón García-Sanz, our expert faculty review the topic of Waldenström’s macroglobulinemia and the role of BTK inhibitors via an exciting program of presentations, patient case studies, interactive workshops and Q&A sessions.
ySA:9
/` 6?e \l\\
Fv
Q-)h
L%a

Please login or register for full access

Register

Already registered?  Login